Current with legislation effective through 5/2/2024
Section 26B-4-245 - Purchasing and use limitations - Exception(1) An individual with a medical cannabis card: (a) may purchase, in any one 28-day period, up to the legal dosage limit of: (i) unprocessed cannabis in a medicinal dosage form; and (ii) a cannabis product in a medicinal dosage form; (b) may not purchase: (i) except as provided in Subsection (2), more medical cannabis than described in Subsection (1)(a); or (ii) if the relevant recommending medical provider did not recommend directions of use and dosing guidelines, until the individual consults with the pharmacy medical provider in accordance with Subsection 26B-4-231(5), any medical cannabis; and (c) may not use a route of administration that the relevant recommending medical provider or the pharmacy medical provider, in accordance with Subsection 26B-4-231(5), has not recommended. (2) (a) A qualified medical provider may petition the department to waive the 28-day period limit described in Subsection (1)(a) for a medical cannabis cardholder if the medical cannabis cardholder: (i) has been diagnosed with a terminal illness; (ii) has a life expectancy of six months or less; and (iii) needs the waiver for palliative purposes. (b) The department shall: (i) consult with the Compassionate Use Board to determine whether the waiver should be granted; (ii) issue a response to the petition within 10 days from the day on which the petition is received. (c) The department may waive the 28-day period limit for no more than 180 days. (d) A petition described in this Subsection (2) may be combined with the petition described in Subsection 26B-1-421(6). Amended by Chapter TBD, 2024 General Session ,§ 47, eff. 5/1/2024.Amended by Chapter TBD, 2024 General Session ,§ 22, eff. 5/1/2024.Added by Chapter 273, 2023 General Session ,§ 37, eff. 7/1/2023, technically renumbered.